Dynamic regulation of Schwann cell enhancers after peripheral nerve injury

Journal of Biological Chemistry

Volumn 290, Issue 11, 2015, Pages 6937-6950

  Hung, Holly A ^a,b   Sun, Guannan ^c   Keles, Sunduz ^c   Svaren, John ^a,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; BINDING SITES; GENE EXPRESSION; GENES; NEURONS; TRANSCRIPTION FACTORS;

CRITICAL DETERMINANT; DISTAL REGULATORY ELEMENTS; DYNAMIC REGULATION; GENE EXPRESSION PATTERNS; LONG TERM STABILITY; NERVE REGENERATION; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM;

TRANSCRIPTION;

EARLY GROWTH RESPONSE FACTOR 2; HISTONE; PROTEIN C JUN; PROTEIN H3K27; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG; TRANSCRIPTION FACTOR SOX;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; MALE; MOUSE; MYELINATION; NERVE FIBER REGENERATION; NONHUMAN; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; RAT; REGULATORY MECHANISM; RUNX2 GENE; SCHWANN CELL; SCIATIC NERVE; ANIMAL; CELL CULTURE; COMPLICATION; DEMYELINATING DISEASE; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; INJURIES; METABOLISM; MYELIN SHEATH; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DEMYELINATING DISEASES; EARLY GROWTH RESPONSE PROTEIN 2; ENHANCER ELEMENTS, GENETIC; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HISTONES; MALE; MICE; MYELIN SHEATH; PERIPHERAL NERVE INJURIES; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, SPRAGUE-DAWLEY; SCHWANN CELLS; SCIATIC NERVE; SIGNAL TRANSDUCTION; SOXE TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS;

EID: 84924913711     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.622878     Document Type: Article

References (94)

1. Brosius Lutz, A., and Barres, B. A. (2014) Contrasting the glial response to axon injury in the central and peripheral nervous systems. Dev. Cell 28, 7-17
2. Patodia, S., and Raivich, G. (2012) Role of transcription factors in peripheral nerve regeneration. Front. Mol. Neurosci. 5, 8
3. Kim, H. A., Mindos, T., and Parkinson, D. B. (2013) Plastic fantastic: Schwann cells and repair of the peripheral nervous system. Stem Cells Transl. Med. 2, 553-557
4. Svaren, J., and Meijer, D. (2008) The molecular machinery of myelin gene transcription in Schwann cells. Glia 56, 1541-1551
5. Pereira, J. A., Lebrun-Julien, F., and Suter, U. (2012) Molecular mechanisms regulating myelination in the peripheral nervous system. Trends Neurosci. 35, 123-134
6. Topilko, P., Schneider-Maunoury, S., Levi, G., Baron-Van Evercooren, A., Chennoufi, A. B., Seitanidou, T., Babinet, C., and Charnay, P. (1994) Krox-20 controls myelination in the peripheral nervous system. Nature 371, 796-799
7. Decker, L., Desmarquet-Trin-Dinh, C., Taillebourg, E., Ghislain, J., Vallat, J. M., and Charnay, P. (2006) Peripheral myelin maintenance is a dynamic process requiring constant Krox20 expression. J. Neurosci. 26, 9771-9779
8. Le, N., Nagarajan, R., Wang, J. Y., Araki, T., Schmidt, R. E., and Milbrandt, J. (2005) Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc. Natl. Acad. Sci. U.S.A. 102, 2596-2601
9. Nagarajan, R., Le, N., Mahoney, H., Araki, T., and Milbrandt, J. (2002) Deciphering peripheral nerve myelination by using Schwann cell expression profiling. Proc. Natl. Acad. Sci. U.S.A. 99, 8998-9003
10. Finzsch, M., Schreiner, S., Kichko, T., Reeh, P., Tamm, E. R., Bösl, M. R., Meijer, D., and Wegner, M. (2010) Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage. J. Cell Biol. 189, 701-712
11. LeBlanc, S. E., Jang, S. W., Ward, R. M., Wrabetz, L., and Svaren, J. (2006) Direct regulation of myelin protein zero expression by the Egr2 transactivator. J. Biol. Chem. 281, 5453-5460
12. Jang, S. W., and Svaren, J. (2009) Induction of myelin protein zero by early growth response 2 through upstream and intragenic elements. J. Biol. Chem. 284, 20111-20120
13. Jones, E. A., Lopez-Anido, C., Srinivasan, R., Krueger, C., Chang, L. W., Nagarajan, R., and Svaren, J. (2011) Regulation of the PMP22 gene through an intronic enhancer. J. Neurosci. 31, 4242-4250
14. Jones, E. A., Brewer, M. H., Srinivasan, R., Krueger, C., Sun, G., Charney, K. N., Keles, S., Antonellis, A., and Svaren, J. (2012) Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22. Hum. Mol. Genet. 21, 1581-1591
15. Denarier, E., Forghani, R., Farhadi, H. F., Dib, S., Dionne, N., Friedman, H. C., Lepage, P., Hudson, T. J., Drouin, R., and Peterson, A. (2005) Functional organization of a Schwann cell enhancer. J. Neurosci. 25, 11210-11217
16. Bondurand, N., Girard, M., Pingault, V., Lemort, N., Dubourg, O., and Goossens, M. (2001) Human connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum. Mol. Genet. 10, 2783-2795
17. Topilko, P., Levi, G., Merlo, G., Mantero, S., Desmarquet, C., Mancardi, G., and Charnay, P. (1997) Differential regulation of the zinc finger genes Krox-20 and Krox-24 (Egr-1) suggests antagonistic roles in Schwann cells. J. Neurosci. Res. 50, 702-712
18. Zorick, T. S., Syroid, D. E., Arroyo, E., Scherer, S. S., and Lemke, G. (1996) The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol. Cell. Neurosci. 8, 129-145
19. Yang, D. P., Kim, J., Syed, N., Tung, Y. J., Bhaskaran, A., Mindos, T., Mirsky, R., Jessen, K. R., Maurel, P., Parkinson, D. B., and Kim, H. A. (2012) p38 MAPK activation promotes denervated Schwann cell phenotype and functions as a negative regulator of Schwann cell differentiation and myelination. J. Neurosci. 32, 7158-7168
20. Napoli, I., Noon, L. A., Ribeiro, S., Kerai, A. P., Parrinello, S., Rosenberg, L. H., Collins, M. J., Harrisingh, M. C., White, I. J., Woodhoo, A., and Lloyd, A. C. (2012) A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo. Neuron 73, 729-742
21. Harrisingh, M. C., Perez-Nadales, E., Parkinson, D. B., Malcolm, D. S., Mudge, A. W., and Lloyd, A. C. (2004) The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation. EMBO J. 23, 3061-3071
22. Shin, Y. K., Jang, S. Y., Park, J. Y., Park, S. Y., Lee, H. J., Suh, D. J., and Park, H. T. (2013) The Neuregulin-Rac-MKK7 pathway regulates antagonistic c-jun/Krox20 expression in Schwann cell dedifferentiation. Glia 61, 892-904
23. Arthur-Farraj, P. J., Latouche, M., Wilton, D. K., Quintes, S., Chabrol, E., Banerjee, A., Woodhoo, A., Jenkins, B., Rahman, M., Turmaine, M., Wicher, G. K., Mitter, R., Greensmith, L., Behrens, A., Raivich, G., et al. (2012) c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron 75, 633-647
24. Rada-Iglesias, A., Bajpai, R., Prescott, S., Brugmann, S. A., Swigut, T., and Wysocka, J. (2012) Epigenomic annotation of enhancers predicts transcriptional regulators of human neural crest. Cell Stem Cell 11, 633-648
25. Nord, A. S., Blow, M. J., Attanasio, C., Akiyama, J. A., Holt, A., Hosseini, R., Phouanenavong, S., Plajzer-Frick, I., Shoukry, M., Afzal, V., Rubenstein, J. L., Rubin, E. M., Pennacchio, L. A., and Visel, A. (2013) Rapid and pervasive changes in genome-wide enhancer usage during mammalian development. Cell 155, 1521-1531
26. Cotney, J., Leng, J., Oh, S., DeMare, L. E., Reilly, S. K., Gerstein, M. B., and Noonan, J. P. (2012) Chromatin state signatures associated with tissuespecific gene expression and enhancer activity in the embryonic limb. Genome Res. 22, 1069-1080
27. Calo, E., and Wysocka, J. (2013) Modification of enhancer chromatin: what, how, and why? Mol. Cell 49, 825-837
28. Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S. A., Flynn, R. A., and Wysocka, J. (2011) A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279-283
29. Creyghton, M. P., Cheng, A. W., Welstead, G. G., Kooistra, T., Carey, B. W., Steine, E. J., Hanna, J., Lodato, M. A., Frampton, G. M., Sharp, P. A., Boyer, L. A., Young, R. A., and Jaenisch, R. (2010) Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. U.S.A. 107, 21931-21936
30. Heintzman, N. D., Hon, G. C., Hawkins, R. D., Kheradpour, P., Stark, A., Harp, L. F., Ye, Z., Lee, L. K., Stuart, R. K., Ching, C. W., Ching, K. A., Antosiewicz-Bourget, J. E., Liu, H., Zhang, X., Green, R. D., et al. (2009) Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108-112
31. Barrette, B., Calvo, E., Vallières, N., and Lacroix, S. (2010) Transcriptional profiling of the injured sciatic nerve of mice carrying the Wld(S) mutant gene: identification of genes involved in neuroprotection, neuroinflammation, and nerve regeneration. Brain Behav. Immun. 24, 1254-1267
32. Jiang, N., Li, H., Sun, Y., Yin, D., Zhao, Q., Cui, S., and Yao, D. (2014) Differential gene expression in proximal and distal nerve segments of rats with sciatic nerve injury during Wallerian degeneration. Neural Regen. Res. 9, 1186-1194
33. Verheijen, M. H., Chrast, R., Burrola, P., and Lemke, G. (2003) Local regulation of fat metabolism in peripheral nerves. Genes Dev. 17, 2450-2464
34. Werner, T., Hammer, A., Wahlbuhl, M., Bösl, M. R., and Wegner, M. (2007) Multiple conserved regulatory elements with overlapping functions determine Sox10 expression in mouse embryogenesis. Nucleic Acids Res. 35, 6526-6538
35. Reiprich, S., Kriesch, J., Schreiner, S., and Wegner, M. (2010) Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells. J. Neurochem. 112, 744-754
36. Fulton, D. L., Denarier, E., Friedman, H. C., Wasserman, W. W., and Peterson, A. C. (2011) Towards resolving the transcription factor network controlling myelin gene expression. Nucleic Acids Res. 39, 7974-7991
37. Ghislain, J., and Charnay, P. (2006) Control of myelination in Schwann cells: a Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities. EMBO Rep. 7, 52-58
38. Jagalur, N. B., Ghazvini, M., Mandemakers, W., Driegen, S., Maas, A., Jones, E. A., Jaegle, M., Grosveld, F., Svaren, J., and Meijer, D. (2011) Functional dissection of the oct6 Schwann cell enhancer reveals an essential role for dimeric sox10 binding. J. Neurosci. 31, 8585-8594
39. Jones, E. A., Jang, S. W., Mager, G. M., Chang, L.-W., Srinivasan, R., Gokey, N. G., Ward, R. M., Nagarajan, R., and Svaren, J. (2007) Interactions of Sox10 and Egr2 in myelin gene regulation. Neuron Glia Biol. 3, 377-387
40. LeBlanc, S. E., Ward, R. M., and Svaren, J. (2007) Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10. Mol. Cell. Biol. 27, 3521-3529
41. Schmidt, D., Wilson, M. D., Spyrou, C., Brown, G. D., Hadfield, J., and Odom, D. T. (2009) ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods 48, 240-248
42. Jang, S. W., LeBlanc, S. E., Roopra, A., Wrabetz, L., and Svaren, J. (2006) In vivo detection of Egr2 binding to target genes during peripheral nerve myelination. J. Neurochem. 98, 1678-1687
43. Sun, G., Chung, D., Liang, K., and Kele¸, S. (2013) Statistical analysis of ChIP-seq data with MOSAiCS. Methods Mol. Biol. 1038, 193-212
44. Liang, K., and Keles, S. (2012) Detecting differential binding of transcription factors using ChIP-Seq. Bioinformatics 28, 121-122
45. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
46. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13
47. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25, 402-408
48. Buecker, C., Srinivasan, R., Wu, Z., Calo, E., Acampora, D., Faial, T., Simeone, A., Tan, M., Swigut, T., and Wysocka, J. (2014) Reorganization of enhancer patterns in transition from naive to primed pluripotency. Cell Stem Cell 14, 838-853
49. Egelhofer, T. A., Minoda, A., Klugman, S., Lee, K., Kolasinska-Zwierz, P., Alekseyenko, A. A., Cheung, M. S., Day, D. S., Gadel, S., Gorchakov, A. A., Gu, T., Kharchenko, P. V., Kuan, S., Latorre, I., Linder-Basso, D., et al. (2011) An assessment of histone-modification antibody quality. Nat. Struct. Mol. Biol. 18, 91-93
50. Sherman, D. L., Wu, L. M., Grove, M., Gillespie, C. S., and Brophy, P. J. (2012) Drp2 and periaxin form Cajal bands with dystroglycan but have distinct roles in Schwann cell growth. J. Neurosci. 32, 9419-9428
51. Srinivasan, R., Sun, G., Keles, S., Jones, E. A., Jang, S. W., Krueger, C., Moran, J. J., and Svaren, J. (2012) Genome-wide analysis of EGR2/SOX10 binding in myelinating peripheral nerve. Nucleic Acids Res. 40, 6449-6460
52. Taniuchi, M., Clark, H. B., and Johnson, E. M. (1986) Induction of nerve growth factor receptor in Schwann cells after axotomy. Proc. Natl. Acad. Sci. U.S.A. 83, 4094-4098
53. Ghislain, J., Desmarquet-Trin-Dinh, C., Jaegle, M., Meijer, D., Charnay, P., and Frain, M. (2002) Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development. Development 129, 155-166
54. Chen, L., Loh, P. G., and Song, H. (2010) Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway. Protein Cell 1, 1073-1083
55. Serrano, I., McDonald, P. C., Lock, F., Muller, W. J., and Dedhar, S. (2013) Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase. Nat. Commun. 4, 2976
56. Ramesh, V. (2004) Merlin and the ERM proteins in Schwann cells, neurons and growth cones. Nat. Rev. Neurosci. 5, 462-470
57. Salzer, J. L. (2012) Axonal regulation of Schwann cell ensheathment and myelination. J. Peripher. Nerv. Syst. 17, Suppl. 3, 14-19
58. Court, F. A., Hewitt, J. E., Davies, K., Patton, B. L., Uncini, A., Wrabetz, L., and Feltri, M. L. (2009) A laminin-2, dystroglycan, utrophin axis is required for compartmentalization and elongation of myelin segments. J. Neurosci. 29, 3908-3919
59. Heller, B. A., Ghidinelli, M., Voelkl, J., Einheber, S., Smith, R., Grund, E., Morahan, G., Chandler, D., Kalaydjieva, L., Giancotti, F., King, R. H., Fejes- Toth, A. N., Fejes-Toth, G., Feltri, M. L., Lang, F., and Salzer, J. L. (2014) Functionally distinct PI 3-kinase pathways regulate myelination in the peripheral nervous system. J. Cell Biol. 204, 1219-1236
60. Yu, W. M., Feltri, M. L., Wrabetz, L., Strickland, S., and Chen, Z. L. (2005) Schwann cell-specific ablation of laminin γ1 causes apoptosis and prevents proliferation. J. Neurosci. 25, 4463-4472
61. Yu, W. M., Chen, Z. L., North, A. J., and Strickland, S. (2009) Laminin is required for Schwann cell morphogenesis. J. Cell Sci. 122, 929-936
62. McKee, K. K., Yang, D. H., Patel, R., Chen, Z. L., Strickland, S., Takagi, J., Sekiguchi, K., and Yurchenco, P. D. (2012) Schwann cell myelination requires integration of laminin activities. J. Cell Sci. 125, 4609-4619
63. Yang, D., Bierman, J., Tarumi, Y. S., Zhong, Y. P., Rangwala, R., Proctor, T. M., Miyagoe-Suzuki, Y., Takeda, S., Miner, J. H., Sherman, L. S., Gold, B. G., and Patton, B. L. (2005) Coordinate control of axon defasciculation and myelination by laminin-2 and -8. J. Cell Biol. 168, 655-666
64. Berti, C., Bartesaghi, L., Ghidinelli, M., Zambroni, D., Figlia, G., Chen, Z. L., Quattrini, A., Wrabetz, L., and Feltri, M. L. (2011) Non-redundant function of dystroglycan and β1 integrins in radial sorting of axons. Development 138, 4025-4037
65. Pellegatta, M., De Arcangelis, A., D'Urso, A., Nodari, A., Zambroni, D., Ghidinelli, M., Matafora, V., Williamson, C., Georges-Labouesse, E., Kreidberg, J., Mayer, U., McKee, K. K., Yurchenco, P. D., Quattrini, A., Wrabetz, L., and Feltri, M. L. (2013) α6β1 and α7β1 integrins are required in Schwann cells to sort axons. J. Neurosci. 33, 17995-18007
66. Nodari, A., Previtali, S. C., Dati, G., Occhi, S., Court, F. A., Colombelli, C., Zambroni, D., Dina, G., Del Carro, U., Campbell, K. P., Quattrini, A., Wrabetz, L., and Feltri, M. L. (2008) α6β4 integrin and dystroglycan cooperate to stabilize the myelin sheath. J. Neurosci. 28, 6714-6719
67. Mogha, A., Benesh, A. E., Patra, C., Engel, F. B., Schöneberg, T., Liebscher, I., and Monk, K. R. (2013) Gpr126 functions in Schwann cells to control differentiation and myelination via G-protein activation. J. Neurosci. 33, 17976-17985
68. Arthur-Farraj, P., Wanek, K., Hantke, J., Davis, C. M., Jayakar, A., Parkinson, D. B., Mirsky, R., and Jessen, K. R. (2011) Mouse schwann cells need both NRG1 and cyclic AMP to myelinate. Glia 59, 720-733
69. Parkinson, D. B., Bhaskaran, A., Arthur-Farraj, P., Noon, L. A., Woodhoo, A., Lloyd, A. C., Feltri, M. L., Wrabetz, L., Behrens, A., Mirsky, R., and Jessen, K. R. (2008) c-Jun is a negative regulator of myelination. J. Cell Biol. 181, 625-637
70. Fontana, X., Hristova, M., Da Costa, C., Patodia, S., Thei, L., Makwana, M., Spencer-Dene, B., Latouche, M., Mirsky, R., Jessen, K. R., Klein, R., Raivich, G., and Behrens, A. (2012) c-Jun in Schwann cells promotes axonal regeneration and motoneuron survival via paracrine signaling. J. Cell Biol. 198, 127-141
71. D'Alonzo, R. C., Selvamurugan, N., Karsenty, G., and Partridge, N. C. (2002) Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation. J. Biol. Chem. 277, 816-822
72. Parkinson, D. B., Bhaskaran, A., Droggiti, A., Dickinson, S., D'Antonio, M., Mirsky, R., and Jessen, K. R. (2004) Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death. J. Cell Biol. 164, 385-394
73. Barutcu, A. R., Tai, P. W., Wu, H., Gordon, J. A., Whitfield, T. W., Dobson, J. R., Imbalzano, A. N., Lian, J. B., van Wijnen, A. J., Stein, J. L., and Stein, G. S. (2014) The bone-specific Runx2-P1 promoter displays conserved three-dimensional chromatin structure with the syntenic Supt3h promoter. Nucleic Acids Res. 42, 10360-10372
74. Gerstein, M. B., Kundaje, A., Hariharan, M., Landt, S. G., Yan, K. K., Cheng, C., Mu, X. J., Khurana, E., Rozowsky, J., Alexander, R., Min, R., Alves, P., Abyzov, A., Addleman, N., Bhardwaj, N., et al. (2012) Architecture of the human regulatory network derived from ENCODE data. Nature 489, 91-100
75. Raha, D., Wang, Z., Moqtaderi, Z., Wu, L., Zhong, G., Gerstein, M., Struhl, K., and Snyder, M. (2010) Close association of RNA polymerase II and many transcription factors with Pol III genes. Proc. Natl. Acad. Sci. U.S.A. 107, 3639-3644
76. Patodia, S., and Raivich, G. (2012) Downstream effector molecules in successful peripheral nerve regeneration. Cell Tissue Res. 349, 15-26
77. Painter, M. W., Brosius Lutz, A., Cheng, Y. C., Latremoliere, A., Duong, K., Miller, C. M., Posada, S., Cobos, E. J., Zhang, A. X., Wagers, A. J., Havton, L. A., Barres, B., Omura, T., and Woolf, C. J. (2014) Diminished Schwann cell repair responses underlie age-associated impaired axonal regeneration. Neuron 83, 331-343
78. Fischer, S., Weishaupt, A., Troppmair, J., and Martini, R. (2008) Increase of MCP-1 (CCL2) in myelin mutant Schwann cells is mediated by MEKERK signaling pathway. Glia 56, 836-843
79. Parkinson, D. B., Langner, K., Namini, S. S., Jessen, K. R., and Mirsky, R. (2002) β-Neuregulin and autocrine-mediated survival of Schwann cells requires activity of Ets family transcription factors. Mol. Cell. Neurosci. 20, 154-167
80. Stewart, H. J. (1995) Expression of c-Jun, Jun B, Jun D and cAMP response element binding protein by Schwann cells and their precursors in vivo and in vitro. Eur. J. Neurosci. 7, 1366-1375
81. Meijer, D., and Svaren, J. (2013) in Patterning and Cell Type Specification in the Developing CNS and PNS (Alvarez-Buylla, A., and Rowitch, D., eds) pp. 759-770, Elsevier, New York
82. Kao, S. C., Wu, H., Xie, J., Chang, C. P., Ranish, J. A., Graef, I. A., and Crabtree, G. R. (2009) Calcineurin/NFAT signaling is required for neu-regulin- regulated Schwann cell differentiation. Science 323, 651-654
83. Biggin, M. D. (2011) Animal transcription networks as highly connected, quantitative continua. Dev. Cell 21, 611-626
84. Taveggia, C., Feltri, M. L., and Wrabetz, L. (2010) Signals to promote myelin formation and repair. Nat. Rev. Neurol. 6, 276-287
85. Visel, A., Blow, M. J., Li, Z., Zhang, T., Akiyama, J. A., Holt, A., Plajzer- Frick, I., Shoukry, M., Wright, C., Chen, F., Afzal, V., Ren, B., Rubin, E. M., and Pennacchio, L. A. (2009) ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457, 854-858
86. Luciano, R. L., and Wilson, A. C. (2003) HCF-1 functions as a coactivator for the zinc finger protein Krox20. J. Biol. Chem. 278, 51116-51124
87. Jacob, C., Christen, C. N., Pereira, J. A., Somandin, C., Baggiolini, A., Lötscher, P., Ozc¸elik, M., Tricaud, N., Meijer, D., Yamaguchi, T., Matthias, P., and Suter, U. (2011) HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells. Nat. Neurosci. 14, 429-436
88. Chen, Y., Wang, H., Yoon, S. O., Xu, X., Hottiger, M. O., Svaren, J., Nave, K. A., Kim, H. A., Olson, E. N., and Lu, Q. R. (2011) HDAC-mediated deacetylation of NF-κB is critical for Schwann cell myelination. Nat. Neurosci. 14, 437-441
89. Timmerman, V., Strickland, A. V., and Züchner, S. (2014) Genetics of Charcot-Marie-Tooth (CMT) Disease within the frame of the human genome project success. Genes 5, 13-32
90. Schaub, M. A., Boyle, A. P., Kundaje, A., Batzoglou, S., and Snyder, M. (2012) Linking disease associations with regulatory information in the human genome. Genome Res. 22, 1748-1759
91. Maurano, M. T., Humbert, R., Rynes, E., Thurman, R. E., Haugen, E., Wang, H., Reynolds, A. P., Sandstrom, R., Qu, H., Brody, J., Shafer, A., Neri, F., Lee, K., Kutyavin, T., Stehling-Sun, S., et al. (2012) Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190-1195
92. Kellis, M., Wold, B., Snyder, M. P., Bernstein, B. E., Kundaje, A., Marinov, G. K., Ward, L. D., Birney, E., Crawford, G. E., Dekker, J., Dunham, I., Elnitski, L. L., Farnham, P. J., Feingold, E. A., Gerstein, M., et al. (2014) Defining functional DNA elements in the human genome. Proc. Natl. Acad. Sci. U.S.A. 111, 6131-6138
93. Houlden, H., Girard, M., Cockerell, C., Ingram, D., Wood, N. W., Goossens, M., Walker, R. W., and Reilly, M. M. (2004) Connexin 32 promoter P2 mutations: a mechanism of peripheral nerve dysfunction. Ann. Neurol. 56, 730-734
94. Brewer, M. H., Ma, K. H., Beecham, G. W., Gopinath, C., Baas, F., Choi, B. O., Reilly, M. M., Shy, M. E., Züchner, S., Svaren, J., and Antonellis, A. (2014) Haplotype-specific modulation of a SOX10/CREB response element at the Charcot-Marie-Tooth disease type 4C locus SH3TC2. Hum. Mol. Genet. 23, 5171-5187